Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Evolution of anti-modified protein antibody responses can be driven by consecutive exposure to different post-translational modifications

Fig. 1

The shift of the AMPA reactivity in individuals at risk of RA and RA patients. A, B Different AMPA (targeting citrullinated, carbamylated or acetylated antibodies) titers as calculated by ELISA with modified fibrinogen. Human serum samples collected at different timepoints were measured. The data are depicted as clustered columns to simplify comparison of each AMPA reactivity between the timepoints, different PTM-reactivities should not be compared directly. The difference between the timepoints was 3 years for individuals at risk and 4 months for RA patients. Shown are inverted AMPA titers of 8 individuals at risk of RA and 5 RA patients

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us